Extensive stage small cell lung cancer trang 1 tải miễn phí từ tailieunhanh

"Extensive stage small cell lung cancer" trang 1 - tải miễn phí từ tailieunhanh

First-line atezolizumab/durvalumab plus platinum–etoposide combined with radiotherapy in extensive-stage small-cell lung cancer

First-line atezolizumab/durvalumab plus platinum–etoposide combined with radiotherapy in extensive-stage small-cell lung cancer

8 2 1

Prognostic ability of lung immune prognostic index in limited-stage small cell lung cancer

Prognostic ability of lung immune prognostic index in limited-stage small cell lung cancer

9 4 1

Irinotecan-platinum combination therapy for previously untreated extensive-stage small cell lung cancer patients: A meta-analysis

Irinotecan-platinum combination therapy for previously untreated extensive-stage small cell lung cancer patients: A meta-analysis

12 76 0

A phase II study of carboplatin and etoposide plus durvalumab for previously untreated extensive-stage small-cell lung cancer (ES-SCLC) patients with a poor performance status (PS): NEJ045A study protocol

A phase II study of carboplatin and etoposide plus durvalumab for previously untreated extensive-stage small-cell lung cancer (ES-SCLC) patients with a poor performance status (PS): NEJ045A study protocol

6 1 1

Efficacy and safety of fuzoparib combined with anlotinib in extensive stage small cell lung cancer after first-line platinum-based chemotherapy: A multi-center, single-arm prospective phase II clinical study (STAMP study)

Efficacy and safety of fuzoparib combined with anlotinib in extensive stage small cell lung cancer after first-line platinum-based chemotherapy: A multi-center, single-arm prospective phase II clinical study (STAMP study)

11 1 1

Carboplatin versus cisplatin in combination with etoposide in the first-line treatment of small cell lung cancer: A pooled analysis

Carboplatin versus cisplatin in combination with etoposide in the first-line treatment of small cell lung cancer: A pooled analysis

7 26 3

Durvalumab for extensive stage of small-cell lung cancer with lambert-eaton myasthenic syndrome

Durvalumab for extensive stage of small-cell lung cancer with lambert-eaton myasthenic syndrome

5 6 1

Belotecan/cisplatin versus etoposide/ cisplatin in previously untreated patients with extensive-stage small cell lung carcinoma: A multi-center randomized phase III trial

Belotecan/cisplatin versus etoposide/ cisplatin in previously untreated patients with extensive-stage small cell lung carcinoma: A multi-center randomized phase III trial

9 51 1